Verdure Sciences’ founder and CEO, Ajay Patel, sat down with VitaFoods Europe to showcase the efficacy of the company's flagship bioavailability-enhanced curcumin ingredient, Longvida.

Landmark studies in the 1990s revealed its ability to downregulate nuclear factor kappa B (NF-κB), a central regulator of inflammation, providing the first molecular evidence of its therapeutic potential.

From early on in Patel’s entrepreneurial career he was intrigued with global supply chains, which included not only sourcing of the raw botanicals, but more importantly the manufacturing of the bioactive extracts.